Comparison of Dalbavancin MIC Values Determined by Etest (AB BIODISK) and Reference Dilution Methods Using Gram-Positive Organisms
Open Access
- 1 August 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (8) , 2988-2990
- https://doi.org/10.1128/jcm.00640-06
Abstract
While standardized microdilution testing methodologies and quality control ranges exist for the novel glycolipopeptide dalbavancin, no testing methods have been described that are immediately available for routine use in clinical laboratories. In this study, we found that the dalbavancin Etest (AB BIODISK, Solna, Sweden) procedure demonstrated a high degree of agreement (100% within ±2 log 2 dilution steps) with the standardized broth microdilution method, validating the use of the Etest as an alternative test for investigational or clinical purposes following regulatory approval.Keywords
This publication has 11 references indexed in Scilit:
- Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Diagnostic Microbiology and Infectious Disease, 2006
- Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensDiagnostic Microbiology and Infectious Disease, 2005
- Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infectionsCurrent Opinion in Infectious Diseases, 2005
- Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure InfectionsClinical Infectious Diseases, 2005
- Origin, structure, and activity in vitro and in vivo of dalbavancinJournal of Antimicrobial Chemotherapy, 2005
- Antistaphylococcal Activity of Dalbavancin, an Experimental GlycopeptideAntimicrobial Agents and Chemotherapy, 2005
- Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methodsJournal of Antimicrobial Chemotherapy, 2004
- Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideInternational Journal of Antimicrobial Agents, 2004
- Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue InfectionsClinical Infectious Diseases, 2003
- Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive ActivityJournal of Clinical Microbiology, 2003